We note that the capability of binding in non-AD tauopathies differs between next-generation tracers as [18F]MK-6240 and [18F]RO-948 both show a high specificity for AD tau aggregates, while they do not seem to significantly bind to non-AD tau aggregates [33, 35]. The gene discussed is MAPT; the disease is Alzheimer disease.